These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27704986)

  • 21. Ophthalmic antihistamines and H1-H4 receptors.
    Wade L; Bielory L; Rudner S
    Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):510-6. PubMed ID: 22918191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major advances in the development of histamine H4 receptor ligands.
    Smits RA; Leurs R; de Esch IJ
    Drug Discov Today; 2009 Aug; 14(15-16):745-53. PubMed ID: 19477292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
    Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
    J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delineation of agonist binding to the human histamine H4 receptor using mutational analysis, homology modeling, and ab initio calculations.
    Jongejan A; Lim HD; Smits RA; de Esch IJ; Haaksma E; Leurs R
    J Chem Inf Model; 2008 Jul; 48(7):1455-63. PubMed ID: 18553960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel histamine H4 receptor ligands and their potential therapeutic applications: an update.
    Kiss R; Keseru GM
    Expert Opin Ther Pat; 2014 Nov; 24(11):1185-97. PubMed ID: 25219452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The histamine H4 receptor and potential therapeutic uses for H4 ligands.
    Jablonowski JA; Carruthers NI; Thurmond RL
    Mini Rev Med Chem; 2004 Nov; 4(9):993-1000. PubMed ID: 15544559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-resolution metabolic profiling towards G protein-coupled receptors: rapid and comprehensive screening of histamine H₄ receptor ligands.
    Kool J; Rudebeck AF; Fleurbaaij F; Nijmeijer S; Falck D; Smits RA; Vischer HF; Leurs R; Niessen WM
    J Chromatogr A; 2012 Oct; 1259():213-20. PubMed ID: 22520160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
    Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
    J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.
    Smits RA; Lim HD; Stegink B; Bakker RA; de Esch IJ; Leurs R
    J Med Chem; 2006 Jul; 49(15):4512-6. PubMed ID: 16854056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands.
    Kottke T; Sander K; Weizel L; Schneider EH; Seifert R; Stark H
    Eur J Pharmacol; 2011 Mar; 654(3):200-8. PubMed ID: 21237145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From three-dimensional GPCR structure to rational ligand discovery.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    Adv Exp Med Biol; 2014; 796():129-57. PubMed ID: 24158804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lead identification and optimization of diaminopyrimidines as histamine H4 receptor ligands.
    Sander K; Kottke T; Proschak E; Tanrikulu Y; Schneider EH; Seifert R; Schneider G; Stark H
    Inflamm Res; 2010 Mar; 59 Suppl 2():S249-51. PubMed ID: 20012148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
    Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histamine receptors: specific ligands, receptor biochemistry, and signal transduction.
    Bakker RA; Timmerman H; Leurs R
    Clin Allergy Immunol; 2002; 17():27-64. PubMed ID: 12113220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cherry-picked ligands at histamine receptor subtypes.
    Sadek B; Stark H
    Neuropharmacology; 2016 Jul; 106():56-73. PubMed ID: 26581501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.
    Igel P; Geyer R; Strasser A; Dove S; Seifert R; Buschauer A
    J Med Chem; 2009 Oct; 52(20):6297-313. PubMed ID: 19791743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refined docking as a valuable tool for lead optimization: application to histamine H3 receptor antagonists.
    Levoin N; Calmels T; Poupardin-Olivier O; Labeeuw O; Danvy D; Robert P; Berrebi-Bertrand I; Ganellin CR; Schunack W; Stark H; Capet M
    Arch Pharm (Weinheim); 2008 Oct; 341(10):610-23. PubMed ID: 18816585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of pK(a) on pyrimidine/pyridine-derived histamine H4 ligands.
    Savall BM; Meduna SP; Venable J; Wei J; Smith RC; Hack MD; Thurmond RL; McGovern P; Edwards JP
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5489-92. PubMed ID: 25455490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological properties of histamine receptor subtypes.
    Arrang JM
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):275-81. PubMed ID: 7920174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bispyrimidines as potent histamine H(4) receptor ligands: delineation of structure-activity relationships and detailed H(4) receptor binding mode.
    Engelhardt H; Schultes S; de Graaf C; Nijmeijer S; Vischer HF; Zuiderveld OP; Dobler J; Stachurski K; Mayer M; Arnhof H; Scharn D; Haaksma EE; de Esch IJ; Leurs R
    J Med Chem; 2013 Jun; 56(11):4264-76. PubMed ID: 23668417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.